We are very pleased to announce the appointment of Dr. Rémi Rabasa-Lhoret as Chair of the Professional Council of Diabetes Québec (CPDQ).
Dr. Rabasa-Lhoret will also head the scientific directions committee of Universi-D, the diabetes school created by Diabetes Québec. The mandate of this new committee will be to determine the action priorities for the education of health professionals and people with diabetes, in addition to ensuring that ethical and moral standards are respected.
A Québec researcher and physician of international renown
Dr. Rabasa-Lhoret has been involved in diabetes research for many years. To say that he devotes a very large part of his time to diabetes does not do justice to his work, nor to the more than 300 articles and excerpts from books that he has published. Passionate, committed to young researchers and, for many years, to our organization — he has been awarded multiple Diabetes Québec scholarships — Dr. Rabasa-Lhoret joins a long tradition of strong, inspiring, charismatic and profoundly generous Professional Council presidents.
When it comes to research, everyone knows that funding is paramount. Thanks to Dr. Rabasa-Lhoret, we have a major ally: holder of the J.-A. DeSève and Lamarre-Gosselin clinical research chairs., he has received numerous awards and bursaries and currently has grants from several national and international organizations.
Active on all fronts
In addition to his duties as vice-president, clinic and clinical research, and director of the diabetes clinic and the metabolic diseases research unit at the Montreal Clinical Research Institute (IRCM), Dr. Rabasa-Lhoret is a full-time endocrinologist, a dimension of his work that is very important to him. Always ready to share his expertise and train the next generation, he is also a full professor at the Department of Nutrition at the Université de Montréal.
Big heart, big brain
Today, his group is researching how to reduce the frequency and consequences of hypoglycemia for patients with type 1 diabetes.
He and his team of researchers are also focusing on diabetes as a secondary effect of cystic fibrosis, the main complication after lung problems. His team is testing new screening strategies and studying ways to control blood glucose.
We are grateful for Dr. Rabasa-Lhoret’s newest involvement with Diabetes Québec and Universi-D. We are very proud to have him with us and warmly welcome him to the team!